Are Medical Stocks Lagging Agenus (AGEN) This Year?

Company Performance - Agenus (AGEN) has returned approximately 27.7% year-to-date, significantly outperforming the average return of 5.6% for the Medical sector [4] - The Zacks Consensus Estimate for Agenus's full-year earnings has increased by 33.3% over the past three months, indicating improved analyst sentiment and a more positive earnings outlook [3] Industry Comparison - Agenus is part of the Medical - Biomedical and Genetics industry, which includes 512 stocks and currently ranks 73 in the Zacks Industry Rank. This industry has gained about 5% year-to-date, showing that Agenus is performing better than its peers [5] - In contrast, another Medical stock, Concentra Group (CON), has returned 18.8% year-to-date and belongs to the Medical Services industry, which is ranked 178 and has moved up by 2% this year [4][6] Zacks Rank - Agenus holds a Zacks Rank of 2 (Buy), which is indicative of its potential to outperform the market in the near term [3] - The Zacks Rank system emphasizes earnings estimates and revisions, highlighting stocks that are likely to beat the market over the next one to three months [3]